SFM
DYN icon

Sphera Funds Management’s Dyne Therapeutics DYN Stock Holding History

Sphera Funds Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Sell
160,594
-232,300
-59% -$4.01M 0.46% 66
2025
Q4 		$7.69M Sell
392,894
-33,624
-8% -$637K 1.49% 19
2025
Q3 		$5.4M Buy
426,518
+205,102
+93% +$2.34M 1.14% 26
2025
Q2 		$2.11M Sell
221,416
-107,846
-33% -$1.19M 0.49% 64
2025
Q1 		$3.44M Buy
329,262
+93,000
+39% +$1.33M 0.79% 38
2024
Q4 		$5.57M Buy
236,262
+179,758
+318% +$5.32M 1.01% 35
2024
Q3 		$2.03M Buy
+56,504
New +$2.25M 0.32% 83
2023
Q3 		– Sell
-119,918
Closed -$1.35M – 91
2023
Q2 		$1.35M Sell
119,918
-99,398
-45% -$1.17M 0.21% 80
2023
Q1 		$2.53M Buy
219,316
+212,167
+2,968% +$2.76M 0.42% 58
2022
Q4 		$82.9K Buy
+7,149
New +$82.7K 0.02% 62
2022
Q1 		– Sell
-105,204
Closed -$1.25M – 79
2021
Q4 		$1.25M Sell
105,204
-119,879
-53% -$1.68M 0.14% 82
2021
Q3 		$3.65M Sell
225,083
-144,631
-39% -$2.56M 0.31% 78
2021
Q2 		$7.78M Sell
369,714
-80,350
-18% -$1.51M 0.53% 55
2021
Q1 		$6.99M Buy
450,064
+350,064
+350% +$6.77M 0.54% 56
2020
Q4 		$2.1M Buy
100,000
+30,000
+43% +$593K 0.19% 85
2020
Q3 		$1.41M Buy
+70,000
New +$1.54M 0.14% 83

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Sphera Funds Management's DYN Position: Q1 2026 in Review

Sphera Funds Management reduced its Dyne Therapeutics (DYN) stake by 59% in Q1 2026, selling an estimated $4.01M and leaving 160,594 shares worth $2.91M. The position accounts for 0.46% of the portfolio, ranked #66.

Sphera Funds Management first reported a position in DYN in Q3 2020 and has held it in 16 quarters since. The position peaked at $7.78M in Q2 2021. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Sphera Funds Management held 160,594 shares of Dyne Therapeutics worth $2.91M as of Q1 2026.
  • Sphera Funds Management sold 232,300 Dyne Therapeutics shares in Q1 2026, an estimated $4.01M.
  • Dyne Therapeutics made up 0.46% of Sphera Funds Management's portfolio in Q1 2026, its #66 holding.
  • Sphera Funds Management first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 16 quarters since.
  • Sphera Funds Management's Dyne Therapeutics position peaked at $7.78M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.